Retatrutide
TRIUMPH-2
Eli Lilly · Phase 3 · Completed · Enrollment 1152
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Retatrutide Dose 1 | Obesity + T2D | n/r | 89 | n/r | n/r |
| Retatrutide Dose 2 | Obesity + T2D | n/r | 89 | n/r | n/r |
| Retatrutide Dose 3 | Obesity + T2D | n/r | 89 | n/r | n/r |
| Placebo | Obesity + T2D | n/r | 89 | n/r | n/r |